Insufficient scRNA-seq data for expression of SCN4A at single-cell level.
Insufficient scRNA-seq data for expression of SCN4A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 1895.91 | 648 / 653 | 84% | 6.89 | 509 / 605 |
breast | 94% | 6225.85 | 431 / 459 | 27% | 0.66 | 306 / 1118 |
muscle | 100% | 21649.91 | 803 / 803 | 0% | 0 | 0 / 0 |
adipose | 99% | 5811.60 | 1196 / 1204 | 0% | 0 | 0 / 0 |
kidney | 13% | 80.22 | 12 / 89 | 40% | 1.87 | 360 / 901 |
adrenal gland | 17% | 126.91 | 45 / 258 | 35% | 0.83 | 80 / 230 |
lymph node | 0% | 0 | 0 / 0 | 48% | 1.42 | 14 / 29 |
spleen | 31% | 192.16 | 74 / 241 | 0% | 0 | 0 / 0 |
skin | 12% | 108.09 | 215 / 1809 | 11% | 0.18 | 51 / 472 |
intestine | 20% | 182.21 | 197 / 966 | 1% | 0.03 | 6 / 527 |
liver | 0% | 1.83 | 1 / 226 | 19% | 0.30 | 79 / 406 |
prostate | 11% | 92.35 | 26 / 245 | 3% | 0.11 | 16 / 502 |
blood vessel | 11% | 109.51 | 152 / 1335 | 0% | 0 | 0 / 0 |
heart | 10% | 57.85 | 85 / 861 | 0% | 0 | 0 / 0 |
lung | 0% | 0 | 0 / 578 | 10% | 0.43 | 113 / 1155 |
bladder | 5% | 46.81 | 1 / 21 | 3% | 0.30 | 16 / 504 |
uterus | 1% | 6.11 | 2 / 170 | 7% | 0.29 | 31 / 459 |
esophagus | 2% | 15.63 | 29 / 1445 | 5% | 0.10 | 9 / 183 |
ovary | 1% | 6.46 | 2 / 180 | 5% | 0.12 | 21 / 430 |
stomach | 4% | 37.81 | 16 / 359 | 1% | 0.03 | 4 / 286 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.25 | 2 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
pancreas | 0% | 1.37 | 1 / 328 | 3% | 0.08 | 6 / 178 |
brain | 0% | 0.19 | 1 / 2642 | 2% | 0.08 | 16 / 705 |
peripheral blood | 1% | 6.28 | 8 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0100001 | Biological process | regulation of skeletal muscle contraction by action potential |
GO_0006936 | Biological process | muscle contraction |
GO_0086002 | Biological process | cardiac muscle cell action potential involved in contraction |
GO_0006814 | Biological process | sodium ion transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0001518 | Cellular component | voltage-gated sodium channel complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005248 | Molecular function | voltage-gated sodium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SCN4A |
Protein name | Type IV sodium channel alpha polypeptide Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4) Sodium channel alpha-subunit |
Synonyms | |
Description | FUNCTION: Pore-forming subunit of a voltage-gated sodium channel complex through which Na(+) ions pass in accordance with their electrochemical gradient. Alternates between resting, activated and inactivated states . Required for normal muscle fiber excitability, normal muscle contraction and relaxation cycles, and constant muscle strength in the presence of fluctuating K(+) levels . . |
Accessions | P35499 Q9H3L9 ENST00000435607.3 O60217 |